Public Policy

Home > Advocacy Updates > Covid > Evidence-Based Recommendations to Protect Infants from S. Aureus

Evidence-Based Recommendations to Protect Infants from S. Aureus

CDC released new recommendations for the prevention and control of Staphylococcus aureus (S. aureus), including methicillin-resistant S. aureus (MRSA) and methicillin-sensitive S. aureus (MSSA), in infants in neonatal intensive care units (NICUs). The guideline makes specific recommendations about interventions to implement in NICUs when there is:  

  •         Evidence of ongoing S. aureus transmission
  •         An increased number of new S. aureus infections
  •         An outbreak